source Post navigation Diabetes Research Institute Announces Breakthrough Transplantation Approach for the Treatment of Type 1 Diabetes at ADA 2024 – InventUM Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD – MD Magazine